NervGen Initiates Expanded Access Policy
The U.S. Food and Drug Administration (FDA) informed the company that an expanded access protocol for NVG-291 may proceedThis ...
Mesoblast Limited: First Three Children to Commence Treatment With Ryoncil
Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has entered into the Medicaid ...
Vegetable Recall Update As FDA Sets Most Serious Concern Level
A Class I recall is issued by the U.S. Food and Drug Administration in situations that can have deadly consequences.
Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates
Completed enrollment of Phase 2 AMPLIFY-7P randomized study; disease-free survival (“DFS”) event-driven interim analysis ...